Sea Crest Wealth Management, LLC Astrazeneca PLC Transaction History
Sea Crest Wealth Management, LLC
- $902 Million
- Q3 2024
A detailed history of Sea Crest Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 17,346 shares of AZN stock, worth $1.13 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
17,346
Previous 17,514
0.96%
Holding current value
$1.13 Million
Previous $1.37 Million
1.03%
% of portfolio
0.15%
Previous 0.16%
Shares
28 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
475MCall Options Held
5.14MPut Options Held
3.06M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.09 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.73 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.42 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.39 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.25 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $202B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...